StratumSkin science, cited
BConditions·10 min·8 sources

PCOS-driven acne and hirsutism: what treats the hormones, not just the skin

Jawline breakouts and excess hair from PCOS both trace back to the same hormonal driver, and skincare alone was never going to be the fix.

Disclosure

Nothing here is sponsored and we earn nothing from anything mentioned. If that ever changes, this box will say so before you read a word of the article.

Evidence at a glance

Combined oral contraceptives
A Cochrane-level evidence plus multi-society guideline consensus. First-line for PCOS-related acne and hirsutism.
Spironolactone
B Guideline-endorsed as an add-on if contraceptives alone aren't enough after six months. Individual trials are small.
Laser/IPL hair removal
B Real randomised evidence, but the whole evidence base is described by its own reviewers as low-certainty and light-skin-biased.
Topical eflornithine
B A real, RCT-backed adjunct that slows hair regrowth, not a cure, and effect reverses when you stop.
Metformin, for acne/hirsutism specifically
C Its real job in PCOS is metabolic. For skin/hair symptoms it's consistently weaker than contraceptives or spironolactone.
Inositol
C A real metabolic-support supplement with genuinely thin evidence for acne and hirsutism specifically.

If you have jawline-and-chin acne that flares around your cycle, alongside hair growth somewhere you'd rather it didn't, and neither has responded to the usual skincare advice, the honest first move isn't a new serum. Both symptoms are commonly driven by the same thing: androgen excess, frequently from polycystic ovary syndrome. That needs a hormonal workup, not a shopping list.

Why the same condition causes both

In PCOS, the ovaries and, to a lesser extent, the adrenal glands produce more androgens than typical, often amplified by insulin resistance, which independently lowers a liver protein (SHBG) that normally keeps testosterone bound and inactive. That means more of it circulates free. That excess androgen acts on two different targets. In oil glands, it drives more sebum and follicle blockage, producing the jawline-and-chin-predominant inflammatory acne pattern common in PCOS. In androgen-sensitive hair follicles on the face, chest and abdomen, it converts fine vellus hairs into coarse terminal ones, producing hirsutism. Same hormone, two different organs responding. That's why treating the acne alone, without addressing the hormone driving it, tends to be an uphill fight.

What actually works, in the order guidelines put it

Combined oral contraceptives are the best-evidenced starting point. A Cochrane review pooling 44 randomised trials across more than 2,250 women found contraceptives outperformed metformin for hirsutism in overweight women, and performed at least as well for acne. Both the 2018 Endocrine Society hirsutism guideline and the 2023 international PCOS guideline, a joint effort across several major reproductive endocrinology societies, list combined contraceptives as first-line pharmacological treatment for PCOS-related acne and hirsutism. This is squarely a prescription conversation: formulation choice and clotting-risk screening are a doctor's job, not a skincare decision.

If contraceptives alone aren't enough after about six months, guidelines recommend adding an antiandrogen, usually spironolactone, rather than starting with it alone, partly because antiandrogens carry a teratogenic risk that requires reliable contraception alongside them. Our own Ingredient Index already grades spironolactone A for adult female hormonal acne generally, from a meta-analysis of 563 women. The PCOS-specific hirsutism trials behind decades of use are real but individually smaller and older, which is why we're grading its role in this specific condition B rather than repeating the general A.

Where the popular supplement doesn't quite hold up

Inositol gets recommended constantly for PCOS, and the largest synthesis of the evidence, a 2024 review pooling 30 randomised trials and over 2,200 participants, commissioned to inform the current international PCOS guideline, found real support for some metabolic benefits, but described the overall evidence as "limited and inconclusive," and specifically found metformin outperformed inositol on hirsutism-adjacent measures. One small earlier trial did report improved acne and hirsutism alongside hormonal markers over six months. That's a real, positive result, from a single 50-person study that the larger, more rigorous review since has not been able to confirm at the skin-and-hair level. Inositol is a reasonable metabolic-support supplement to discuss with your doctor. It is not, on current evidence, a proven fix for the acne or hair growth specifically.

Metformin: the right drug, occasionally for the wrong symptom

Metformin's real, well-supported job in PCOS is insulin sensitisation and metabolic/ovulatory outcomes. For acne and hirsutism specifically, the same Cochrane review found it consistently underperformed combined contraceptives overall. But a smaller, older head-to-head trial against a different combined pill found metformin actually did better on hirsutism score, apparently by lowering insulin rather than by blocking androgens. One trial pointing the other way doesn't overturn a Cochrane review of 44 trials, but it's a fair reminder that individual studies in this area don't always agree with each other. If your doctor has prescribed metformin for PCOS, it's likely working on the metabolic side of the condition. Don't expect it to be your primary acne or hair treatment on its own.

For the hair itself: laser and topical options

A 2024 systematic review of laser and light-based hirsutism treatment in PCOS found real benefit: alexandrite laser outperformed IPL alone, and combining laser with contraceptives or metformin beat laser by itself. The reviewers were unusually candid about their own evidence's limits: only six studies, 423 people total, rated low-certainty overall, and thin data specifically on darker skin types. That's a real gap for a treatment many of our readers would be considering. Topical eflornithine cream, used alongside laser or on its own, has genuine randomised trial support for slowing hair regrowth, with the effect reversing once you stop using it. It's a maintenance adjunct, not a cure, and it treats the hair directly rather than the hormone behind it.

The actual first step

PCOS is diagnosed with a hormone panel, often an ultrasound, and by ruling out other causes of androgen excess, not by matching your symptoms to a website. If the jawline-acne-plus-hair-growth pattern sounds like you, the useful next move is a gynaecologist or endocrinologist, not a longer skincare routine. Everything graded above is meant to be a conversation you can have well-informed, not a self-directed treatment plan.

The short version

Combined oral contraceptives are the best-evidenced first step for PCOS-driven acne and hirsutism, with spironolactone added if that's not enough. Laser hair removal and topical eflornithine have real evidence for the hair specifically. Inositol is a reasonable metabolic supplement with thinner evidence than its popularity suggests for the skin and hair symptoms themselves. None of it replaces an actual hormonal diagnosis.

This is general education, not medical advice. Nothing here accounts for your history, your medication or your skin, and none of it replaces assessment by a qualified clinician. Where we describe what research found, that is a description of a study — not a promise about you.

References

  1. Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 2020.ACochrane review, 44 RCTs, 2,253 women·Contraceptives beat metformin for hirsutism in overweight women (low-certainty evidence), with no meaningful difference for acne, and combining both may beat either alone for hirsutism.DOI 10.1002/14651858.CD005552.pub3
  2. Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Multi-society international guideline, 2023.AGuideline, joint effort across major reproductive endocrinology societies·Endorses combined oral contraceptives as first-line for PCOS-related hyperandrogenism (acne, hirsutism), with antiandrogens added if response is inadequate after 6 months.PubMed 37580861
  3. Ghanem H, et al. Efficacy and safety of oral spironolactone for women with acne vulgaris: a systematic review and meta-analysis of randomized placebo-controlled trials. Journal of Cosmetic Dermatology, 2025.AMeta-analysis, 5 RCTs, 563 women·General adult female hormonal acne, not PCOS-restricted. This is the same citation already behind spironolactone's Grade A on our Ingredient Index.PubMed 40823723DOI 10.1111/jocd.70411
  4. Fitz V, Graca S, Mahalingaiah S, et al. Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines. Journal of Clinical Endocrinology & Metabolism, 2024.CMeta-analysis, 30 RCTs (19 pooled), 2,230 participants·Found some metabolic benefit, but explicitly called overall evidence 'limited and inconclusive', and metformin outperformed inositol on hirsutism-adjacent measures.PubMed 38163998DOI 10.1210/clinem/dgad762
  5. Zacchè MM, et al. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecological Endocrinology, 2009.CSmall trial, n=50, 6 months·Reported reduced hirsutism and acne alongside hormonal improvement. Single small study with limited comparator, and not confirmed at the skin/hair level by the larger 2024 synthesis above.PubMed 19551544
  6. Harborne L, Fleming R, Lyall H, Norman J, Sattar N. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 2003.CHead-to-head trial·The comparator was Dianette (ethinyl estradiol plus cyproterone acetate), not spironolactone. Metformin actually came out ahead on hirsutism score and patient self-assessment, apparently by lowering insulin levels rather than by blocking androgens. That's the opposite of the assumption this claim is usually used to support, and worth reading alongside the larger Cochrane result above rather than on its own.PubMed 12970273
  7. Tan K, Coster T, Mousa A, et al. Laser and light-based therapies for hirsutism management in women with polycystic ovarian syndrome: a systematic review. JAMA Dermatology, 2024.BSystematic review, 6 studies (4 RCTs), 423 participants·Alexandrite laser outperformed IPL alone, and combining with metformin or contraceptives beat laser alone. Authors themselves flagged low-certainty evidence and limited data on darker skin types.PubMed 38630483
  8. Wolf JE, Shander D, Huber F, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. International Journal of Dermatology, 2007.BPooled randomised trials, ~600 women, 24 weeks·Faster, greater improvement than vehicle, but effect reverses on discontinuation. Studied in facial hirsutism generally, not PCOS-restricted.PubMed 17214730DOI 10.1111/j.1365-4632.2006.03079.x

Related condition hub

PCOS-driven acne & hirsutism

Your turn

Did this hold up? Tell us honestly — especially if it didn’t.

Anonymous. Stored in your browser.

The Sunday study

One paper a week, explained properly

We pick a single new study, tell you what it measured, how many people it measured it in, and whether it should change anything you're doing — plus the two articles we published that week. No panic, and no hype.

We don't recommend products yet. When we do, they'll be things you can actually buy in India, any affiliate link will be labelled as one, and a commission will never buy a recommendation.

One email each Sunday. Unsubscribe in one click.